mRNA vaccines benefited from the statistical power of having a widespread pandemic. Trials could simply do a double blind test and check how often the treatment subjects got covid vs. control. With thousands of study participants and a fast moving virus statistical power is reached quickly.
For cancers, the disease is slow moving and there are fewer patients seeking experimental treatment. Fewer still are willing to chance that they are part of a control group. The patients who do participate are likely taking multiple other treatments, limiting the statistical power of the trial.
Do you really need a control group for this kind of study? The growth of cancer has been studied for well over a century, with millions of cases; what would a hundred more (to take a random number) tell you? (BTW, this is a real question, not a sarcasm!)
The control group is needed to measure process properties / systematic error.
It does not need to be a placebo group. Previous data at the same hospital does not help because the regular medicine does not run according to study protocols.
You cannot use 10 women to grow a fetus in 1 month. Likewise, you cannot have a good understanding of the long term risks without having s study that runs longterm.
40 weeks is by convention from estimated last menstrual period, which is of course about 2 weeks prior to fertilization - so the actual gestastional period is closer to 38 weeks (that is closer to 9 months than 10 months).
This is a phase I study. The point here is to establish safety. The study believes this treatment could have a benefit for patients, but they aren’t sure if there are unknown risks. This is to establish that there aren’t any unknown risks. The eligible patient population has already advanced on therapy (meaning the current standard of care hasn’t worked).
Getting patients to any sort of long-term response is the goal here. If there are any long term risks, that would be considered a good outcome (because the patient is still alive to have long term effects).
Any further (heritable genetic) risks are mitigated as the patients specifically are excluded if they are planning on having children in the near future.
Luckily we've been studying mRNA vaccines for over 50 years, which gave us a very good understanding of the long-term effects. What we really needed to test for was short-term effects + efficacy. These are easy to determine when 1% of the population is infected at the time of your clinical trial.
I can't stress how much the COVID mRNA deployment wasn't a "#yolo" moment like some folks still continue to insist.
It was a product of years and years of meticulous research and development. This put us at the finish line, and all we had to do was get over it.
We also got the J&J vaccine out in basically the same amount of time - because like the mRNA vaccines, the adenoviral vector vaccine platform had about 50 years of research and development behind it.
To use your analogy, we started with 10 ladies each 8 months pregnant, and we got them over the line in a month.
That doesn't mean the pregnancy took a month - just that we had a head start.
Not to be overly pedantic, but having the idea in the 1970s didn't count for much, because no one could get mRNA into human cells until around 1987. The first attempt at a vaccine was around maybe 1993. I mean, directionally your right but saying "we've been studying mRNA vaccines for over 50 years" isn't really correct.
Vaccines either produce side effects in 3-6 months or they don't.
There's no hidden time bomb in all the people who were vaccinated last year.
The FDA doesn't require long term safety studies for vaccines, and all the coronavirus vaccines have met the requirements. Nothing has been rushed.
We have a good understanding of this because the side effects are entirely dominated by autoimmune conditions, and we understand from the field of rheumatology how those arise.
We don't need to study pregnant women for another 5 years to see if any more babies pop out after the first one. Pregnancy is done in 9 months. Autoimmune side effects from vaccines happen in 3-6.
It is wild how heavily downvoted this is. Everything in this comment is correct (I also note none of the downvotes could be bothered to present any rebuttal to the claims).
It's unfalsifiable. "We don't know of any way this could happen, thus it will not happen" is not a claim that can be rebutted until it is proven wrong. "We don't have any reason to believe thalidomide is unsafe" was another such claim.
"This has never happened before in the recorded history of rheumatology and immunology" is the claim, backed up with pretty well fleshed out mechanistic theories of what happens during vaccination and how the body responds to it.
It also is falsifiable. Find the side effect that falsifies it.
And it has survived the prior testing of 100 years of vaccination.
They actually can, they're not a brand new never before seen kind of magic. They're using mechanisms that viruses and vaccines have used and which we've studied for hundreds of years. We don't actually know nothing about them.
Covid vaccines have already had multiple recalls due to unforeseen heart complications. These complications were, of course, "impossible" before they began occurring.
You cannot, by definition, foresee what unforeseen complications may arise with anything. Especially something as quickly made and widely disseminated as these vaccines. There may not be any "known" way a side effect could occur after 6 months. That does not philosophically mean anything about a risk existing. A lot, and I mean a lot, of medications have no side effects until you take them for years, and then suddenly there are issues. Adderall use is correlated with Parkinsons if you take it for over a decade. Some of these are foreseeable, and some were "no known way it could happen" until it did.
> This complex, specific and intricate process spans a number of months. Ultimately, though, in the absence of further stimulation by new copies of the spike protein, the immune response settles down, and effector cells—those directly and transiently involved in fighting the virus—decrease in frequency. Instead memory cells are established, poised to quickly ramp up production of antibodies, and even to replicate themselves, settling into their biological niches in our bodies until called upon once more if we happen to get infected. (This is what confers immunity to the coronavirus over the long run.) Antibody concentrations, some weeks after immunization, begin to reach their peak concentration in our blood, ultimately plateauing and beginning their slow decline. After this point, the risk of severe immunization-related complications doesn’t increase. Quite the opposite, in fact: it declines to virtually nothing after about three months. The six-month endpoint for these products is thus a rather conservative timeframe. Forget five or ten years: the way your immune system works does not allow for such long-term safety concerns.
For cancers, the disease is slow moving and there are fewer patients seeking experimental treatment. Fewer still are willing to chance that they are part of a control group. The patients who do participate are likely taking multiple other treatments, limiting the statistical power of the trial.